Monophasic cross-linked HA filler with 24 mg/ml medical-grade hyaluronic acid, featuring <0.03 EU/ml endotoxin levels and <0.5 ppm BDDE residues. Advanced dialysis technology ensures 98.7% homogeneity for precise superficial dermis integration. FDA-compliant formulation with 0.3% lidocaine enables pain-free correction of dynamic wrinkles and volumetric restoration in sensitive zones (periocular, perioral).

Key Advantages:

Advanced Cross-Linking Technology:

• Monodisperse particle distribution (80-120μm)
• 6-step purification process
• Optimal G-prime for superficial layering
• Zero animal-derived components

Packaging Configuration:

⚫ 2×1.1ml prefilled syringes
⚫ 4×30G sterile needles
⚫ RTU (room temperature stable)
⚫ Batch-tracked vials

Clinical Protocol:

1. Strict aseptic technique required
2. Mid-dermis deposition (0.8-1.2mm)
3. Retrograde linear threading
4. Post-injection massage contraindicated
5. Single-patient use only

*For licensed practitioners only. Contains lidocaine hydrochloride. Individual results may vary ±15% based on tissue compliance and injection technique. Not for vascular danger zones. Discontinue if persistent erythema occurs.